{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:31:55Z","timestamp":1762918315977,"version":"build-2065373602"},"reference-count":41,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Rabies is an ancient disease that is responsible for approximately 59,000 human deaths annually. Bats (Order Chiroptera) are thought to be the original hosts of rabies virus (RABV) and currently account for most rabies cases in wildlife in the Americas. Vaccination is being used to manage rabies in other wildlife reservoirs like fox and raccoon, but no rabies vaccine is available for bats. We previously developed a recombinant raccoonpox virus (RCN) vaccine candidate expressing a mosaic glycoprotein (MoG) gene that protected mice and big brown bats when challenged with RABV. In this study, we developed two new recombinant RCN candidates expressing MoG (RCN-tPA-MoG and RCN-SS-TD-MoG) with the aim of improving RCN-MoG. We assessed and compared in vitro expression, in vivo immunogenicity, and protective efficacy in vaccinated mice challenged intracerebrally with RABV. All three candidates induced significant humoral immune responses, and inoculation with RCN-tPA-MoG or RCN-MoG significantly increased survival after RABV challenge. These results demonstrate the importance of considering molecular elements in the design of vaccines, and that vaccination with either RCN-tPA-MoG or RCN-MoG confers adequate protection from rabies infection, and either may be a sufficient vaccine candidate for bats in future work.<\/jats:p>","DOI":"10.3390\/vaccines9121436","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T03:21:05Z","timestamp":1638847265000},"page":"1436","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Molecular Modifications on the Immunogenicity and Efficacy of Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates in Mice"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6673-737X","authenticated-orcid":false,"given":"Carly M.","family":"Malav\u00e9","sequence":"first","affiliation":[{"name":"U.S. Geological Survey, National Wildlife Health Center, Madison, WI 53711, USA"},{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-8426","authenticated-orcid":false,"given":"Jaime","family":"Lopera-Madrid","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4242-6945","authenticated-orcid":false,"given":"Lex G.","family":"Medina-Mag\u00fces","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonie E.","family":"Rocke","sequence":"additional","affiliation":[{"name":"U.S. Geological Survey, National Wildlife Health Center, Madison, WI 53711, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-6150","authenticated-orcid":false,"given":"Jorge E.","family":"Osorio","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"key":"ref_1","unstructured":"WHO (2021, May 17). Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs099\/en\/."},{"key":"ref_2","unstructured":"World Health Organization (2005). WHO Expert Consultation on Rabies, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2460\/javma.253.12.1555","article-title":"Rabies surveillance in the United States during 2017","volume":"253","author":"Ma","year":"2018","journal-title":"J. Am. Vet. Med Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wallace, R.M., Gilbert, A., Slate, D., Chipman, R., Singh, A., Wedd, C., and Blanton, J.D. (2014). Right place, wrong species: A 20-year review of rabies virus cross species transmission among terrestrial mammals in the United States. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107539"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vetmic.2010.02.001","article-title":"Human rabies due to lyssavirus infection of bat origin","volume":"142","author":"Johnson","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1590\/S1020-49892009000300010","article-title":"Rabies transmitted by vampire bats to humans: An emerging zoonotic disease in Latin America?","volume":"25","author":"Schneider","year":"2009","journal-title":"Rev. Panam. De Salud P\u00fablica"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20837","DOI":"10.1073\/pnas.1308817110","article-title":"Resolving the roles of immunity, pathogenesis, and immigration for rabies persistence in vampire bats","volume":"110","author":"Blackwood","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1098\/rspb.2012.0538","article-title":"Ecological and anthropogenic drivers of rabies exposure in vampire bats: Implications for transmission and control","volume":"279","author":"Streicker","year":"2012","journal-title":"Proc. R. Soc. B Boil. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2460\/javma.2005.227.785","article-title":"Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995\u20132003","volume":"227","author":"Sidwa","year":"2005","journal-title":"J. Am. Veter- Med. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virusres.2005.03.012","article-title":"Status of oral rabies vaccination in wild carnivores in the United States","volume":"111","author":"Slate","year":"2005","journal-title":"Virus Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0264-410X(98)80108-4","article-title":"Experimental rabies infection and oral vaccination in vampire bats (Desmodus rotundus)","volume":"16","author":"Brochier","year":"1998","journal-title":"Vaccine"},{"key":"ref_12","unstructured":"Centers for Disease Control and Prevention (CDC) (2009). Human vaccinia infection after contact with a raccoon rabies vaccine bait-Pennsylvania, 2009. MMWR Morb. Mortal. Wkly. Rep., 58, 1204\u20131207."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4269\/ajtmh.2008.79.647","article-title":"Vaccinia virus in humans and cattle in southwest region of Sao Paulo state, Brazil","volume":"79","author":"Megid","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3390\/v6082974","article-title":"Lyssaviruses and Bats: Emergence and Zoonotic Threat","volume":"6","author":"Banyard","year":"2014","journal-title":"Viruses"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tmaid.2012.01.003","article-title":"The other rabies viruses: The emergence and importance of lyssaviruses from bats and other vertebrates","volume":"10","author":"Calisher","year":"2012","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The spread and evolution of rabies virus: Conquering new frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Stading, B., Ellison, J.A., Carson, W.C., Satheshkumar, P.S., Rocke, T.E., and Osorio, J.E. (2017). Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005958"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1637\/9315-032410-Reg.1","article-title":"Characterization of recombinant raccoonpox vaccine vectors in chickens","volume":"54","author":"Hwa","year":"2010","journal-title":"Avian Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(96)00072-2","article-title":"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model","volume":"14","author":"Wyatt","year":"1996","journal-title":"Vaccine"},{"key":"ref_20","unstructured":"Earl, P.L., Moss, B., Wyatt, L.S., and Carroll, M.W. (2001). Generation of recombinant vaccinia viruses. Curr. Protoc. Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Meza, D.K., Broos, A., Becker, D.J., Behdenna, A., Willett, B.J., Viana, M., and Streicker, D.G. (2020). Predicting the presence and titer of rabies virus neutralizing antibodies from low-volume serum samples in low-containment facilities. BioRxiv.","DOI":"10.1101\/2020.04.24.060095"},{"key":"ref_22","unstructured":"Rasband, W.S. (2021, September 06). ImageJ, Available online: https:\/\/imagej.nih.gov\/ij\/."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Smith, T.G., and Gilbert, A.T. (2017). Comparison of a micro-neutralization test with the rapid fluorescent focus inhibition test for measuring rabies virus neutralizing antibodies. Trop. Med. Infect. Dis., 2.","DOI":"10.3390\/tropicalmed2030024"},{"key":"ref_26","unstructured":"Meslin, F.X., Kaplan, M.M., and Koprowski, H. (1996). A Rapid Fluorescent Focus Inhibition Test (RFFIT) for Determining Rabies Virus-Neutralizing Antibody, World Health Organization. [4th ed.]. Laboratory Techniques in Rabies."},{"key":"ref_27","unstructured":"Meslin, F.X., Kaplan, M.M., and Koprowski, H. (1996). The flourescent antibody test. Laboratory Techniques in Rabies, World Health Organization."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00253-011-3297-0","article-title":"Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence","volume":"91","author":"Wang","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(02)00557-1","article-title":"Recombinant raccoon pox vaccine protects mice against lethal plague","volume":"21","author":"Osorio","year":"2002","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2017.07.007","article-title":"Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis","volume":"190","author":"Kou","year":"2017","journal-title":"Immunol. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1574-695X.1997.tb01045.x","article-title":"Comparative study of DNA-based immunization vectors: Effect of secretion signals on the antibody responses in mice","volume":"18","author":"Haddad","year":"1997","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105567","DOI":"10.1016\/j.pep.2019.105567","article-title":"Novel strategy for expression and characterization of rabies virus glycoprotein","volume":"168","author":"Zhao","year":"2020","journal-title":"Protein Expr. Purif."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Moore, S.M., and Hanlon, C.A. (2010). Rabies-specific antibodies: Measuring surrogates of protection against a fatal disease. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000595"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.83.20.7947","article-title":"Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine","volume":"83","author":"Rupprecht","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biotechadv.2011.08.022","article-title":"Mammalian cell protein expression for biopharmaceutical production","volume":"30","author":"Zhu","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: A vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2013.03.044","article-title":"Beta-actin variant is necessary for Enterovirus 71 replication","volume":"433","author":"Lui","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physiolgenomics.00025.2005","article-title":"GAPDH as a housekeeping gene: Analysis of GAPDH mRNA expression in a panel of 72 human tissues","volume":"21","author":"Barber","year":"2005","journal-title":"Physiol. Genom."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas-Canales, E.M., Gigante, C.M., Greenberg, L., Velasco-Villa, A., Ellison, J.A., Satheshkumar, P.S., Medina-Mag\u00fces, L.G., Griesser, R., Falendysz, E., and Amezcua, I. (2020). Clinical presentation and serologic response during a rabies epizootic in captive common vampire bats (Desmodus rotundus). Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5010034"},{"key":"ref_41","unstructured":"Malav\u00e9, C.M., Lopera-Madrid, J., Medina-Mag\u00fces, L.G., Rocke, T.E., and Osorio, J.E. (2021, December 02). In Vitro Expression, Immunogenicity, and Efficacy Data from Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates Tested in Mice, Available online: https:\/\/www.sciencebase.gov\/catalog\/item\/6196c135d34eb622f691acc6."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/12\/1436\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:39:48Z","timestamp":1760168388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/12\/1436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,4]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["vaccines9121436"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9121436","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2021,12,4]]}}}